Biointerfaces Background 01

Category: Translational Research

The Shea group investitages antigen-conjugated nanoparticle treatment
UM Invests in BI Startup Greenmark Biomedical
February 22, 2019

Through the Michigan Investment in New Technology Startups (MINTS) initiative, UM will invest $500K in GreenMark Medical, a startup based on technologies developed by BI Director, Joerg Lahann.

Read Story
Default Featured Image
BI Startup Evoq Therapeutics profiled in Crain’s Detroit
January 3, 2019

Crain’s Detroit features Evoq Therapeutics, a startup company co-founded by James Moon and Anna Schwendeman.

Read Story

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us